Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00726_DB01175_nanopub.RAsjcXBaxrSZya69H3ia2ldKwA1_2NjeElvBB9-PeOEMs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00726_DB01175 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB01175 label "DDI between Trimipramine and Escitalopram - The SSRI, Escitalopram, may decrease the metabolism and clearance of Trimipramine. Increased risk of serotonin syndrome. Monitor for changes in Trimipramine efficacy and toxicity if Escitalopram is initiated, discontinued or dose changed. [drugbank_resource:DB00726_DB01175]" assertion.
- drugbank_resource:DB00726_DB01175 identifier "drugbank_resource:DB00726_DB01175" assertion.
- drugbank_resource:DB00726_DB01175 title "DDI between Trimipramine and Escitalopram - The SSRI, Escitalopram, may decrease the metabolism and clearance of Trimipramine. Increased risk of serotonin syndrome. Monitor for changes in Trimipramine efficacy and toxicity if Escitalopram is initiated, discontinued or dose changed." assertion.
- drugbank:DB01175 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB01175 assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB01175 assertion.